Gyms overflowing, menus full of small plates and a surge in 'Ozempic face' supplements are just a few ways in which weight-loss jabs are altering society ...
The Canadian Press on MSN12h
Canadian scientist wins Breakthrough Prize for discovery of hormone used in Ozempic, MounjaroA Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes ...
At least 14 states already cover the cost of GLP-1 medications for obesity treatment for patients on Medicaid. Indiana is not ...
The Centers for Medicare Medicaid Services (CMS) announced it will not proceed with a Biden administration proposal to expand ...
The Centers for Medicare & Medicaid Services will not cover drugs when exclusively used for weight loss, like Ozempic or Wegovy, the Trump administration announced.
Advances recognized by science’s most lucrative awards include Large Hadron Collider experiments and groundbreaking ...
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...
It’s why Webb, of Rochester, is fighting for the passage of Indiana Senate Bill 140. The bill, which passed the Indiana ...
Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.
The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden ...
Experts across healthcare debunk 15 common myths about GLP-1 medications—covering everything from access and cost to ...
Trump previously floated a 25% tariff on all imported drugs, though they were unaffected by recent reciprocal levies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback